| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,277 |
8,029 |
$852K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,237 |
4,133 |
$275K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,635 |
2,599 |
$127K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
723 |
723 |
$102K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,975 |
2,949 |
$73K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
753 |
753 |
$67K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,899 |
3,863 |
$56K |
| 99051 |
|
1,736 |
1,714 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
272 |
269 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
164 |
163 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
42 |
42 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
12 |
12 |
$1K |
| 87428 |
|
32 |
32 |
$940.48 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
237 |
234 |
$938.89 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$837.07 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$588.48 |
| 90688 |
|
168 |
168 |
$142.76 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
249 |
246 |
$114.72 |